People
Science with soul

Our work has global impact, and we're a team with a global outlook. We are proud of our diverse voices and work hard to create a rich and varied workplace. Just like a healthy ecosystem.

We're all about the power of people. That means working together and putting humans at the heart of our process to get the best results.

We focus on supporting underserved communities in the tropics, who are directly impacted by climate change, food insecurity and health inequality. We aim to remedy the challenges faced daily by local growers and consumers by listening carefully to what they have to say. That way, we are constantly learning from and adapting to the specific needs of our farmers on the frontline.

Closer to home, we have an employee-driven partnership with the UK charity, FoodCycle, which creates meals for people at risk of food insecurity. Together, we’ve served hundreds of meals to the most vulnerable members of our community here in Norwich.

Our Values
TEAM

Gilad is an experienced AgriTech entrepreneur and investor, who is deeply passionate about utilizing cutting-edge technologies in solving real world challenges. He is a former Navy Ship Commander in the Israel Defense Forces (Ret. Lieutenant Colonel) and holds a Bs.C. in Industrial Engineering from Tel Aviv University and an MBA from the UCLA Anderson School of Management.

Chief Executive Officer

Gilad M. Gershon

Ofir previously served as the Director of R&D in the Crop Protection Division at Evogene. Prior to this, Dr. Meir worked as a Discovery Lead at Monsanto, leading a team of scientists in developing innovative production systems. He had previously worked at Rosetta Green, later acquired by Monsanto. Dr. Meir received his PhD in life sciences from the Weizmann Institute of Science in Israel.

Chief Technology Officer

Ofir Meir

Eyal is an accomplished virologist and RNA biologist with a broad experience in the Agri-Tech industry. His seminal PhD work at the Hebrew University of Jerusalem became the basis for an agricultural-genetics startup named Beeologics, which he helped build until its acquisition by Monsanto. He later served as the Chief Science Officer for Forrest Innovation, an agricultural BioTech company, before founding Tropic Biosciences.

Chief Science Officer

Eyal Maori

Jack is an accomplished commercial leader, experienced in both market-leading and early-stage genomics and life science companies. Prior to joining Tropic Biosciences, he held senior roles in sales and customer support at companies including Illumina, Bionano Genomics and Unchained Labs. Before embarking on his commercial career, Jack completed his PhD and Post Doc at the Sainsbury laboratory where he used Gene Silencing as a tool to study disease resistance mechanisms in plants.

Chief Business Officer

Jack Peart

Ralph is an accomplished finance executive with over 20 years’ experience in strategic financial leadership positions across Europe, South America, Asia Pacific and Canada, working for companies such as Syngenta, Actelion Pharmaceuticals (now part of Johnson & Johnson), Shell Petroleum and various medical technology companies.

Chief Finance Officer

Ralph Fraundorfer

Karen comes from a long and successful career in Senior HR roles within the pharmaceutical industry with GSK where she supported GSK's most-senior leaders and their teams in Research and Development globally. Karen has led HR across all disciplines from an early career in scientific recruitment, to designing and managing a global induction programme, talent management and succession planning as well as managing R&D function start up and new team development globally. Renowned for putting respect for people at the heart of everything she does, together with a passion and drive to make good great and great even better, Karen is well positioned to help drive the organisation and its leaders to the next level of our development as a company.

VP Human Resources

Karen Marklew

Dan has over 20 years of experience in novel seed and plant product development in most agricultural relevant countries around the world including, China, India and Thailand. Prior to joining Tropic Biosciences, he led the Vegetable Seed R&D organisation at Syngenta where he also learnt the importance of individual customer connection and understanding. Building, scaling and nurturing people centric organisations to meet growing agricultural needs is what excites Dan today. He received his PhD in gene and protein engineering from the University Portsmouth, UK.

VP Product Development

Daniel Fox

Eli is a seasoned Intellectual Property executive, specialising in leading global IP strategy of biotech and pharma companies from start-ups to multinationals. Prior to joining Tropic Biosciences Eli was Principal Patent Counsel at Quark Pharmaceuticals, responsible for the company's siRNA-based clinical-stage therapeutics.

He also held positions in leading private practice firms both in the UK and Israel. He holds a PhD in Molecular Genetics from the Weizmann Institute of Science (Israel) and an MBA specialising in Bio-Medical Management.

VP Intellectual Property

Eli Gilsohn

Keiran is an experienced Corporate Real Estate and Facilities Operations Professional, who has managed a large portfolio of facilities across EMEA, Asia Pacific, US and Latin America supporting Commercial, R&D and Manufacturing operations. In his previous role as Executive Director of Corporate Real Estate at Gilead Sciences Inc. US, Keiran was responsible for setting up the company’s operations in over 35 countries encompassing: Environment, Health and Safety (EHS), Maintenance, Security, Site Operations and Lab Services. Prior to this, Keiran was Head of FM (UK) for Novartis Pharmaceuticals, supporting multiple business units across their UK operations.

Keiran is a Chartered Engineer with a degree in Electrical, Electronic and Communication Engineering and an MBA from Durham University.

VP R&D Operations and Facilities

Keiran Ferguson

Cassie is a scientist and a registered patent attorney with over a decade of experience in intellectual property, regulatory, licensing & corporate law, and IP due diligence. She has global experience protecting IP and driving regulatory approvals in the areas of biotechnology and bioengineering from plants to animals, in private practice and in-house for U.S. and U.K. publicly traded companies. Cassie completed Harvard Business School’s General Management Program, holds a B.S. in Molecular Genetics with honors from The Ohio State University, an M.S. with an emphasis on Biomathematics from North Carolina State University, and obtained her law degree with honors from Drake University.

Regulatory Counsel

Cassie J. Edgar

Mr. Vigodman is a highly experienced executive with extensive expertise across the agricultural and life-sciences industries.

From 2014 to 2017 he served as President and Chief Executive Officer of Teva Pharmaceutical Industries, Israel’s largest company and the leading global generic pharmaceutical company. From 2010 to 2014, he served as President and Chief Executive Officer of Adama Agricultural Solutions (FKA Makhteshim Agan Industries), the world’s leading generic crop protection company and a top-6 global agronomical company. From 2001 to 2009, he served as President and Chief Executive Officer of Strauss Group, a multinational food and beverage company.

From 2014 to Present he has been serving as a member of the Advisory Committee to the Israel National Economic Council (Prime Minister Office). From 2005 to 2009 he served as a Member of the Advisory Board to the Governor of the Bank of Israel. From 1998 to 2001 he served as a member of the Israel Securities Authority Plenary Governing Board.

Chairman of the Board

Erez Vigodman

Dr. David Lawrence is a former Non-executive Director at Syngenta. Prior to that, he was the Head of Research & Development at Syngenta from 2002 to 2009. Past roles include Council membership of BBSRC, and Chair of the Industrial Biotechnology Strategy Advisory Panel, and Directorship of Rothamsted Research. Currently he is Chair of the UK Knowledge Transfer Network Ltd, Chair of Agrimetrics Ltd, a Director of the Rainbow Seed Fund, and a member of the Nuffield Council on Bioethics.

Non-Executive Director

David Lawrence

Niccolò is a founder at Five Seasons Ventures who has been investing in Food Tech since 2014, and created and managed a portfolio of 10 high-profile Food Tech companies, including Impossible Foods, Clara Foods, Beyond Meat, JUST, Perfect Day and Clear Labs, as part of a leading European family office. His experience includes sourcing, diligence and growth strategy for early stage companies in Food Tech and, more broadly, in tech.

Previously, he was Project Manager at strategy consulting firm Monitor Group (now Monitor Deloitte), focusing on food ingredients, healthcare, consumer and industrial goods, across strategic marketing and organisational engagements. Prior to that, he worked as part of the McKinsey & Co. Management Matters initiative on management best practices and their impact on productivity and efficiency in the public (healthcare and education) and private (manufacturing) sectors.

Niccolò holds a BSc in Management from Bocconi University and an MSc in International Affairs from the London School of Economics and Peking University.

Non-Executive Director

Niccolo Manzoni

Qi Li joined Temasek in 2015 and has been focusing on investments across food and agribusiness value chain globally. She moved to London in 2019. Prior to this, Qi Li was a Vice Principal at Rothschild, a global leading financial advisory firm for seven years, first in Paris, France, and then in Beijing, China. Qi Li holds a Master of Finance degree in Institut des Sciences Politiques de Paris (IEP Paris), and a B.A. degree in Beijing Foreign Studies University.

Non-Executive Director

Qi Li

Ben Belldegrun is the Co-Founder and Managing Partner of Aliment Capital, a $490M growth capital fund dedicated to food and agriculture technology, backed by leading university endowments, institutions, foundations and family offices. His responsibilities include investments, portfolio management and board related activities across investments in food and agriculture productivity, resource efficiency, health/nutrition, and sustainability in the industry supply chain. Prior to launching Aliment, Belldegrun was a co-founder and managing partner of Lodestone Natural Resources. Previously, he was a portfolio manager at Brevan Howard Asset Management concentrating on agriculture investments within the $300 million Natural Resources Fund. He has more than 15 years of successful agriculture investing experience. Belldegrun holds a BA in Economics from Columbia University and an MBA from the UCLA Anderson School of Management.

Non-Executive Director

Ben Belldegrun

Jamie Rowles is part of the founding team of Tropic Biosciences and provides strategic support across Tropic’s financing and corporate development growth. Jamie is an experienced investor, operator, and lawyer committed to building companies applying cutting-edge technologies to drive environmental impact. He recently launched an early-stage climate fund – the Planet Fund, previously built an environmental vehicle anchored by Sky and has past experience across the full spectrum of private and public financings in both the US, UK, and Middle Easy. Jamie holds an MBA at UCLA Anderson School of Management in California, where he received the Price Entrepreneurial Award, and a LLB from Bristol University.

Counsel & Company Secretary

Jamie Rowles

​Dr. Pétiard has a long career in industrial research and is the former Director of the Nestlé Corporate Research & Development Center for Plant Science and Technology, an institute he founded and developed in Tours, France. He has considerable experience in Plant Science applications and supply chain for Consumer Good Companies with pharmaceutical, cosmetic, and food industries. His technical expertise in agriculture and plant breeding/biotechnology has been applied to a variety of crops – including both speciality and tropical plants.

Advisor, Coffee Genetics

Vincent Pétiard

Barbara Mazur worked for DuPont Pioneer/Corteva Agrisciences; prior to her retirement, she was Vice President, Technology Acquisition Strategy, with responsibilities for venture investments and external collaborations. Prior to this she led trait technology programs, and before that had responsibility in DuPont Pioneer and in DuPont for crop protection traits. Barbara earned her A.B. from the University of California at Los Angeles and her Ph.D. from The Rockefeller University. She was a postdoctoral research fellow and research assistant professor in the Department of Biophysics & Theoretical Biology at the University of Chicago. She has served on several scientific boards and panels, including the Board on Biology of the National Academy of Sciences, the National Science Foundation Biology Advisory Board, the Board of the International Society for Plant Molecular Biology, numerous university research advisory boards and as a board observer for startups.

Advisor, Biotechnology

Barbara J. Mazur

David Baulcombe was a student in Botany at Leeds (BSc) and Edinburgh (PhD) Universities. After periods in Montreal, the University of Georgia and the Cambridge Plant Breeding Institute he spent 20 years at the Sainsbury Laboratory, Norwich. He joined Cambridge University in 2007 as Royal Society Research Professor and now as Regius Professor of Botany.

David is a Fellow of the Royal Society and a foreign associate member of the US National Academy of Sciences. His awards include the 2006 Royal Medal of the Royal Society, the 2008 Lasker Award for basic biomedical sciences, the Wolf Prize for Agriculture in 2010 and the 2012 Balzan Prize. He was knighted in June 2009.

Advisor, RNAi & Plant Genetics

Sir David Baulcombe

Professor Paul Teng is an agricultural scientist experienced in tropical agrifood systems and food security. He researched and taught epidemiology and plant disease management in North America, Africa and Asia after his graduation from Lincoln College, University of Canterbury, New Zealand.

Paul has been recognized for his phytopathology work through being awarded the Eriksson Prize in Plant Pathology, and election as Fellow of The American Phytopathological Society, the International Society for Plant Pathology and The World Academy of Science. He was awarded an Honorary D.Sc. by Murdoch University, Australia for his food security research.

Professor Paul Teng is Managing Director, NIE International Pte. Ltd., and Adjunct Senior Fellow, Centre for Non-Traditional Security Studies, RSIS, both of Nanyang Technological University Singapore. He is also concurrently Senior Adviser (AgriFood) to A*STAR (Singapore’s premier technology R&D organization with substantial investments in agtech and the food industry). Paul previously held leadership positions in the International Rice Research Institute, the Worldfish Centre, Monsanto Company and U.S. universities.

Advisor, Rice Genetics

Paul Teng

Sedef Koktenturk is a Managing Partner and the Chief Operating Officer at Blue Horizon. She is the Impact Partner in the investment teams and leads on firmwide impact management and ESG integration, client operations and technology. Sedef has 20 years of capital markets experience from leading global investment firms including Generation Investment Management and Goldman Sachs. She started her career at PricewaterhouseCoopers in financial advisory and holds an MBA from the Columbia Business School in New York. Sedef is also an Olympian; she represented Turkey in the 2008 Beijing Olympic Games in windsurfing.

Advisor, ESG & Impact

Sedef Koktenturk​

Neil Cameron holds expertise in the field of advanced materials and processes, as he co-leads the sustainable packaging practice at Emerald Technology Ventures with Fredric Petit. As a Partner at Emerald, Neil is delighted to be involved in all phases of the investment process, helping young deep-tech start-ups become heavy-hitters in the circular economy. Neil also supports the open innovation initiatives of some of the world’s leading corporate partners as they achieve their sustainability and profitability goals. In the Emerald Portfolio, past and present Board roles include Phase Change Energy Solutions, Tropic Biosciences, actnano, Lucintech, and others.

Neil’s academic background is in advanced materials and holds a PhD in Chemistry from McGill University and a BSc in Chemistry and Biochemistry from the University of King’s College (Dalhousie University). Neil is a product of the global village and is happy to commiserate in English or French.

Advisor, ESG & Impact

Neil Cameron

Micol Chiesa is an experienced environmental economist, angel investor, start-up mentor, and circular economy champion. Currently, Micol is Head of Climate Science at Planet Fund, where she leads the firm’s technical research, due diligence, and scientific strategy. While supporting Planet Fund’s portfolio companies, Micol sits on the technical advisory board of Tropic Biosciences. Prior to her work at Planet Fund, Micol was Head of Impact Investing at Five Seasons Ventures, the largest foodtech impact fund in Europe. Before setting out as an investor, Micol spent several years at Bain and Company helping fast-moving innovators scale with purpose in the private equity and energy and resources industries, as well as working for the World Bank in agriculture and food services.

Micol holds an MA in environmental economics from Johns Hopkins SAIS, Energy Resources and Environment Programme, and a PhD in environmental finance from the University of Oxford, Smith School of Enterprise and the Environment.

Advisor, ESG & Impact

Micol A. Chiesa